Key result
Surgery by experienced surgeons (≥25 operations/year) was associated with higher repair success (94.7% vs 87.0%, P=0.001) and was an independent risk factor for mortality (HR 2.64, P=0.002).
Why the study?
The study was conducted to assess the impact of surgeon experience on the outcomes of degenerative mitral valve disease.
Does surgery by an experienced surgeon improve outcomes and reduce mortality in patients with severe mitral regurgitation caused by degenerative mitral valve disease?
Cohort (n=575)
Does surgery by an experienced surgeon improve outcomes and reduce mortality in patients with severe mitral regurgitation caused by degenerative mitral valve disease?
Absolute Event Rate: 94.7% vs 87%
p-value: p=0.001
Higher surgeon volume in degenerative mitral valve surgery is associated with higher repair rates and improved survival.
Supports referral to experienced surgeons for degenerative mitral repair; extends volume-outcome observations but remains hypothesis-generating.
Objective: To assess the impact of surgeon experience on the outcomes of degenerative mitral valve disease. Methods: We reviewed all patients who had surgery for degenerative mitral valve disease between 2011-2016. Experienced surgeon was defined as performing 25 mitral valve operations/year. Patient characteristics and outcomes were compared. Multivariable analysis was performed to identify factors associated with MR recurrence. Survival analysis for mortality was done using Kaplan Meier curve and Cox proportional Hazard method. Results: There were 575 patients treated by 9 surgeons for severe mitral regurgitation caused by degenerative mitral valve disease between 2011-2016. Three experienced surgeons performed 77.2% of the operations. Patients treated by less experienced surgeons had worse comorbidity profile and were more likely to have an urgent or emergent operation (P=0.001). Experienced surgeons were more likely to attempt repair (P=0.024), to succeed in repair (94.7% vs 87%, P=0.001), had shorter cross-clamp times (P=0.001), and achieved higher repair rate (81.3% vs 69.7%, P=0.005). Experienced surgeons were more likely to use neochordae (P=0.001) and less likely to use chordae transfer (P=0.001). Surgeon experience was not associated with recurrence (moderate or higher MR) within the first two years after surgery but was an independent risk factor for mortality (HR= 2.64, P=0.002). Conclusions: Techniques of degenerative mitral valve surgery differ with surgeon experience, with higher rates of repair and better outcomes associated with more experienced surgeons.
No takes yet. Share an insight, caveat, or question.
Yousef et al. (2020) conducted a cohort in severe mitral regurgitation caused by degenerative mitral valve disease (n=575). Experienced surgeon (≥25 mitral valve operations/year) vs. Less experienced surgeons was evaluated on repair success (p=0.001). Surgery by experienced surgeons (≥25 operations/year) was associated with higher repair success (94.7% vs 87.0%, P=0.001) and was an independent risk factor for mortality (HR 2.64, P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: